P153 Clinical effects of 5-azacitidine five days/monthly schedule in three symptomatic low-risk (IPSS: 0-1) myelodysplastic patients
C. Fili, C. Bergonzi, C. Skert, M. Malagola, A.M. Roccaro, A. Peli, E. Capuzzi, D. RussoVolume:
31
Year:
2007
Language:
english
Pages:
1
DOI:
10.1016/s0145-2126(07)70223-0
File:
PDF, 51 KB
english, 2007